Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Scopus

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

 

Publications


📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025


📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025


📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024


📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024


Bojan Miletic | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Bojan Miletic | Medicine and Dentistry | Best Researcher Award

University of Rijeka | Croatia

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 📚

Assoc. Prof. Dr. Bojan Miletic began his academic journey at the University of Rijeka, Croatia, where he studied medicine from 1986 to 1992. His early education laid a strong foundation for his diverse career in internal medicine, cardiology, and rehabilitation. After completing his medical degree, Dr. Miletic went on to specialize in internal medicine, cardiology, and geriatric rehabilitation through various educational institutions, including the Clinical Hospital Center Rijeka, the Lucerne Cantonal Hospital in Switzerland, and several other renowned centers across Europe. His rigorous training allowed him to acquire multiple certifications and broaden his expertise in interdisciplinary medicine.

Professional Endeavors 🏥

Dr. Miletic has a distinguished professional career, spanning over two decades in various hospitals and rehabilitation centers across Europe. He currently serves as an Associate Professor and Co-Head of the Department of Clinical Medical Sciences at the University of Rijeka, Croatia, where he engages in both student education and clinical research. Alongside his academic duties, he also works as a Specialist in Internal Medicine and Cardiology at Policlinic Primari in Rijeka and the General Hospital and Homeland War Veterans Hospital in Ogulin, Croatia. His work in clinical settings, including the establishment of new medical units, has contributed significantly to the field.

Throughout his career, Dr. Miletic held leadership roles at several prestigious institutions, including the Lucerne Cantonal Hospital in Switzerland, the Zurich Rehabilitation Center, and Herzpark Hardterwald in Germany. His roles ranged from Co-Head of Rehabilitation Centers to Head of Cardiac Rehabilitation Departments. He also contributed to the development of new rehabilitation centers, providing education and training to nurses, physiotherapists, and doctors.

Contributions and Research Focus 🔬

Dr. Miletic has made significant contributions to clinical research, particularly in the areas of geriatric rehabilitation, cardiology, and internal medicine. His work has addressed key health issues such as depression in the elderly, rehabilitation outcomes, and diagnostic challenges in internal medicine. Dr. Miletic’s research has resulted in numerous articles published in respected journals, such as Medicina, J Sport Rehabil, Lancet Oncol, and Int J Cardiol. His studies often focus on innovative treatment methods, diagnostic challenges, and interdisciplinary approaches to medicine, aiming to improve patient outcomes and healthcare practices across various specialties.

Accolades and Recognition 🏅

Dr. Miletic’s contributions to the medical field have not gone unnoticed. He has received several prestigious awards, including the Green Card for contributing to the development of a culture of respect and promotion of patients' rights by the Croatian Movement for the Patients' Rights. He has also been honored by the Croatian Medical Association for his merits in advancing the medical profession and his health and humanitarian efforts. His excellence in clinical research, education, and leadership has earned him recognition from various professional bodies.

Impact and Influence 🌍

With over 20 years of experience in clinical and academic settings, Dr. Miletic has profoundly impacted the fields of cardiology, internal medicine, and rehabilitation. His role in establishing new departments and hospitals has improved medical services and patient care. His international experience and collaborations across Europe have allowed him to influence healthcare practices and medical education in multiple countries. His ongoing participation in congresses, scientific activities, and as a member of numerous professional societies further amplifies his influence on the global medical community.

Legacy and Future Contributions 🔮

Dr. Miletic’s career is marked by his unwavering commitment to improving patient care, advancing medical research, and educating the next generation of healthcare professionals. His work in developing new rehabilitation centers and his leadership in clinical research will continue to shape the future of healthcare in Europe and beyond. As an active member of professional societies like the European Society of Cardiology and the European Society of Cardiovascular Imaging, Dr. Miletic is poised to make continued contributions to the medical field, ensuring that his legacy as a leader in cardiology, rehabilitation, and internal medicine endures for years to come.

Publications


  • 📄Depression and Its Effect on Geriatric Rehabilitation Outcomes in Switzerland’s Aging Population

      • Authors: Bojan Miletic, Antonia Plisic, Lejla Jelovica, Jan Saner, Marcus Hesse, Silvije Segulja, Udo Courteney, Gordana Starcevic-Klasan
      • Journal: Medicina
      • Year: 2025

  • 📄Icterus provoked by Echinococcus mimicking a tumor: A diagnostic challenge

      • Authors: Bojan Miletic, Yves Sutter, Elefteri Buset, Silvije Segulja, Marcus Hesse
      • Journal: Travel Medicine and Infectious Disease
      • Year: 2025

  • 📄The Physical Activity and Dietary Habits of Nursing Students

    • Authors: Željko Jovanović, Maja Šarić, Bojan Miletic
    • Journal: Medical Research Archives
    • Year: 2024

  • 📄Virtual reality in the education of instrumentation techniques for nurses/technicians

    • Authors: Marija Spevan, Željko Jovanović, Bojan Miletic
    • Journal: World of Health
    • Year: 2024

  • 📄Infarkt miokarda s elevacijom ST segmenta kao indikacija za hitan medicinski transport u Opću bolnicu Zadar

    • Authors: Slavica Balgavi, Silvije Šegulja, Bojan Miletic
    • Event: 27th Congress of Emergency Medicine with International Participation
    • Year: 2024

 

Véronique Bricout | Health Professions | Women Research Award

Prof. Véronique Bricout | Health Professions | Women Research Award

Enseignant Chercheur Université Grenoble Alpes | France

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 🎓

Prof. Véronique Bricout's academic journey began with a foundation in health and life sciences, earning her undergraduate degree with high distinction in 1987. She excelled in graduate studies, completing her Master's in Health and Life Sciences with honors and a focus on evaluating physical capacities in children. Her doctoral research, awarded with the highest distinctions in 1994, explored the physiological impact of physical activity on muscular testosterone receptors. This was complemented by her postdoctoral accreditation to supervise research (H.D.R.), investigating gonadic steroids' role in muscular function.

Professional Endeavors 🌍

Prof. Bricout has cultivated a multifaceted career blending academia, research, and leadership. Starting as a physical education teacher in the early 1990s, she transitioned to a long-standing role as a researcher and professor at the University of Grenoble Alpes in 2003. Her expertise extended to administrative roles, including Officer in charge of Disability and Accessibility (2020–2021) and Vice-President for Student Life, Disability, and Health (2021–2024).

Contributions and Research Focus 🧪

Prof. Bricout's research spans hormonal physiology, exercise science, and the intersection of physical activity and disability. Her contributions include groundbreaking studies on gender differences in physical activity patterns, motor skills, and cardiorespiratory capacity in individuals with autism and Down syndrome. Her peer-reviewed publications in high-ranking journals and book chapters underscore her commitment to advancing knowledge in sports medicine, sleep disorders, and autonomic responses to exercise.

Accolades and Recognition 🏆

Throughout her career, Prof. Bricout has been recognized for her academic excellence and leadership. Her research has been widely cited, with notable publications addressing critical health challenges in marginalized groups. She has represented her work internationally, presenting at prestigious congresses like the European Respiratory Society and the International Society for Biomedical Research on Alcoholism.

Impact and Influence 🌟

Prof. Bricout's work has had a profound impact on understanding the physiological and psychological dimensions of exercise in individuals with disabilities. Her leadership roles have facilitated the implementation of inclusive policies at the University of Grenoble Alpes, reflecting her dedication to improving accessibility and support systems for students.

Legacy and Future Contributions 🌱

As a pioneering researcher and educator, Prof. Bricout leaves a legacy of innovation and advocacy. Her ongoing projects and publications promise to further bridge the gaps in health sciences, sports medicine, and disability studies. Her work continues to inspire the next generation of scholars and practitioners in her field.

 

Publications


  • 📜 Sex Differences in Sleep and Physical Activity Patterns in Autism Spectrum Disorder
    Author(s): Bricout V, Covain S, Paterno J, Guinot M
    Journal: Clocks & Sleep
    Year: 2024

  • 📜 Gender Differences, Motor Skills, and Physical Fitness Heterogeneity in Adults with Down Syndrome
    Author(s): Covain S, Bailleuil S, Nguyen TD, Guinot M, Doutreleau S, Bricout V
    Journal: Journal of Clinical Medicine
    Year: 2023

  • 📜 Sleep Apnea in People with Down Syndrome: Causes and Effects of Physical Activity?
    Author(s): Nguyen DT, Bricout V, Tran TH, Duong SQ
    Journal: Frontiers in Neurology
    Year: 2023

  • 📜 Psychological Distress Mediates the Connection Between Sleep
    Author(s): Bègue L, Nguyen TD, Vezirian K, Zerhouni O, Bricout V
    Journal: Aggressive Behavior
    Year: 2022

  • 📜 Classification of Factors Affecting Sleep in Individuals with Down Syndrome
    Author(s): Nguyen TD, Guinot M, Bailleuil S, Doutreleau S, Bricout V
    Journal: Brain Sciences
    Year: 2021

 

Shinya Watanabe | Neuroscience | Best Research Award

Assist. Prof. Dr. Shinya Watanabe | Neuroscience | Best Research Award

University of Tsukuba | Japan 

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Shinya Watanabe’s academic journey began at Chiba University’s Department of Pharmaceutical Sciences. However, driven by a passion for medicine, he transitioned to the University of Tsukuba, earning a Bachelor’s degree in Medicine in 2005 and later a Ph.D. in Medicine in 2015. His diverse educational pursuits also include a specialized program in Medical Innovation Strategy at Chiba University, reflecting his commitment to integrating clinical expertise with innovative healthcare solutions.

Professional Endeavors 🩺

Dr. Watanabe’s illustrious medical career spans over two decades, marked by extensive hands-on experience across several leading hospitals in Japan. Starting as a resident at Tsukuba University Hospital, he later specialized as a neurosurgeon in institutions like Hitachi General Hospital and Tsukuba Medical Center. His tenure with the Pharmaceuticals and Medical Devices Agency (PMDA) between 2017 and 2020 saw him influencing drug, device, and regenerative medicine reviews, underscoring his role as a key figure in Japan’s medical regulatory landscape. Currently, he serves as a Lecturer at the University of Tsukuba’s Faculty of Medicine, contributing to both clinical practice and medical education.

Contributions and Research Focus 🔬

Dr. Watanabe’s research spans a variety of critical areas, including neurotrauma, cancer treatment, and dementia. His expertise has been certified by prestigious bodies such as the Japan Neurosurgical Society and the Japanese Society of Dementia. A thought leader in his field, Dr. Watanabe has actively developed innovative treatments, such as headache management techniques, and remains a sought-after expert in advancing medical technology and therapeutic strategies.

Accolades and Recognition 🏆

Dr. Watanabe’s exceptional contributions have been celebrated with numerous awards, such as the 12th Nose Award and the Research Encouragement Award from the Japanese Society for Diencephalo-Pituitary Tumors. In 2020, his groundbreaking interdisciplinary work earned him the Joyo Bank Award, highlighting his ability to bridge clinical practice with innovative technologies.

Impact and Influence 🌍

Through his extensive clinical and academic roles, Dr. Watanabe has shaped the practice of neurosurgery and medical device innovation in Japan. His contributions to the PMDA and ARO Council have had far-reaching effects, ensuring that healthcare products meet rigorous safety and efficacy standards. He has also inspired future generations of medical professionals through his dedication to education at the University of Tsukuba.

Legacy and Future Contributions 🌟

Dr. Watanabe’s legacy lies in his ability to blend clinical precision with innovation. As a pioneer in interdisciplinary research, he continues to push the boundaries of medical science, ensuring a brighter future for patients worldwide. His ongoing contributions to neuroscience, cancer treatment, and dementia care are set to redefine the standards of modern medicine, establishing him as a beacon of excellence in healthcare. With a career characterized by unwavering dedication and transformative achievements, Assist. Prof. Dr. Shinya Watanabe embodies the spirit of medical innovation and compassion.

 

Publications


📄"A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology"

  • Author: Watanabe, S.; Shibata, Y.; Ishikawa, E.
  • Journal: Neurology International
  • Year: 2024

📄"A Retrospective Cohort Study of Stereotactic Radiosurgery for Vestibular Schwannomas: Comparison of Two Age Groups (75 Years or Older vs. 65–74 Years)"

  • Author: Watanabe, S.; Yamamoto, M.; Aiyama, H.; Akutsu, H.; Ishikawa, E.
  • Journal: Surgical Neurology International
  • Year: 2024

📄"Recent Status of Phase I Clinical Trials for Brain Tumors: A Regulatory Science Study of Exploratory Efficacy Endpoints"

  • Author: Watanabe, S.; Nonaka, T.; Maeda, M.; Arakawa, Y.; Ishikawa, E.
  • Journal: Therapeutic Innovation and Regulatory Science
  • Year: 2024

📄"Empirical Myoelectric Feature Extraction and Pattern Recognition in Hemiplegic Distal Movement Decoding"

  • Author: Anastasiev, A.; Kadone, H.; Marushima, A.; Matsumaru, Y.; Ishikawa, E.
  • Journal: Bioengineering
  • Year: 2023

📄"Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials"

  • Author: Watanabe, S.; Nonaka, T.; Maeda, M.; Arakawa, Y.; Ishikawa, E.
  • Journal: Therapeutic Innovation and Regulatory Science
  • Year: 2023

 

Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

China Pharmaceutical University | China                    

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Rengui Saxu began his academic journey at Shenyang Medical College, where he pursued a degree in Clinical Medicine Science from 2012 to 2017. During his studies, he completed an internship at Shenyang Central Hospital in 2017, gaining hands-on experience in clinical practice. His academic dedication earned him the National Encouragement Scholarship and the title of Outstanding Graduate, marking his potential as a rising scholar in the field of medicine. Continuing his academic path, Dr. Saxu pursued a Master of Pharmacy Engineering at Tianjin University of Science & Technology from 2017 to 2020. During this time, he took on leadership roles, notably serving as the Head of the Academic Department of the University Graduate Association. His work in pharmacy engineering was recognized with the Zhixing Scholarship for Postgraduate Students.

Professional Endeavors 🏅

Dr. Saxu is currently engaged in advanced research as a Ph.D. candidate in Pharmacology at China Pharmaceutical University (2021-2025). He works under the supervision of Yong Yang, a prominent figure in pharmacological research, and Harvest F. Gu, Chief Scientist at Karolinska Medical School in Sweden. His research spans crucial areas in pharmacology, focusing on drug development and the mechanisms of disease, particularly in relation to diabetes, kidney disease, and cancer.

Contributions and Research Focus 🔬

Dr. Saxu's research contributions are vast, with a focus on pharmacological innovations and therapeutic interventions for diseases like diabetes and cancer. One of his notable patents is a Chinese patent for a method involving selenium-substituted axitinib, which offers anti-tumor applications. His academic publications reflect his deep involvement in cutting-edge research:

  • His studies on asymmetries in adrenal glands and their role in glucocorticoid production provide insights into diabetes-related obesity.
  • He has explored the therapeutic potential of Abelmoschus manihot (L.) in treating diabetic nephropathy via the gut-kidney axis, contributing to the advancement of herbal medicine in disease management.
  • Dr. Saxu has also investigated how Huangkui capsules inhibit aldosterone synthesis in diabetic kidney disease, a promising direction for traditional Chinese medicine.

Accolades and Recognition 🏆

Dr. Saxu's academic excellence has been recognized through numerous prestigious awards:

  • National Encouragement Scholarship
  • Zhixing Scholarship for Postgraduate Students
  • Doctoral Research Incentive Scholarship
  • Outstanding Doctoral Scholarship

These accolades reflect his commitment to research and innovation in the field of pharmacology.

Impact and Influence 🌍

Dr. Saxu's research has had a considerable impact on the medical and pharmacological fields, particularly in the treatment of diabetes and kidney disease. His work on drug therapy and natural compound-based treatments has opened new avenues for understanding and combating complex diseases. His research not only influences medical practices in China but also has international implications, especially in areas related to drug efficacy and safety.

Legacy and Future Contributions 🚀

Dr. Saxu’s future contributions are poised to advance pharmacological research significantly, especially in the areas of cancer therapy and chronic disease management. As a researcher under highly esteemed mentors like Yong Yang and Harvest F. Gu, his ongoing work will likely lead to breakthroughs in targeted therapies and personalized medicine. In the years to come, Dr. Saxu's work will continue to shape the landscape of pharmaceutical sciences, offering hope for more effective and less harmful treatment options. His contributions to medical research, especially in oncology and diabetes, will leave a lasting legacy in global healthcare.

 

Publications


📜 Higher Steroid Production in the Right Adrenal Gland Compared to the Left One in db/db Mice, a Model of Type 2 Diabetic Obesity

  • Authors: Rengui Saxu, Qiming Luo, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

📜 Asymmetries of Left and Right Adrenal Glands in Neural Innervation and Glucocorticoids Production

  • Authors: Rengui Saxu, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

 

Maria Margariti | Medicine and Dentistry | Best Researcher Award

Assoc Prof Dr. Maria Margariti | Medicine and Dentistry | Best Researcher Award

1st Department of Psychiatry, Medical School, National and Kapodistrian University of Athens | Greece

Author Profile 

Google Scholar

Early Academic Pursuits 🎓

Dr. Maria Margariti embarked on her academic journey at the National and Kapodistrian University of Athens, where she earned her Diploma in Medicine in 1989. Her dedication to psychiatry led her to complete a fellowship training program in community psychiatry in the UK in 1991-1992. By 1995, she had achieved her Psychiatric Specialty Licensure and continued her education with a Ph.D. in Psychiatric Education, which she completed in 2000. Her early academic foundation laid the groundwork for a successful career in psychiatry.

Professional Endeavors 🏥

Since 2002, Dr. Margariti has been an integral part of the National and Kapodistrian University of Athens, where she progressed from Lecturer to her current position as Associate Professor of Psychiatry. She has been pivotal in various leadership roles, including heading the psychiatric emergencies and outpatient clinic at Eginition Hospital. Additionally, she founded the Crisis Intervention and Management Unit for severe psychiatric disorders, showcasing her commitment to advancing psychiatric care.

Contributions and Research Focus 🔍

Dr. Margariti’s research primarily focuses on psychiatric education and the psychopathology of psychosis. Her extensive clinical observations led to the recognition of a complex emotional state called ‘Psychotic Arousal.’ This groundbreaking concept highlights an increased affective tone and symptoms of experiential alienation in acute psychosis. Her work has opened new avenues for understanding the neurobiology of emotions and consciousness in the context of psychiatric disorders.

Accolades and Recognition 🏆

Dr. Margariti’s contributions to the field have not gone unnoticed. She has published 45 journals and is cited 716 times, reflecting the impact of her research. She has been involved in developing clinical guidelines for treating schizophrenia and has served as an advisor in various professional psychiatric organizations. Her leadership roles and innovative research have solidified her reputation in the psychiatric community.

Impact and Influence 🌍

Through her educational initiatives, Dr. Margariti has shaped the training of numerous medical students and trainee psychiatrists. Her involvement in postgraduate courses and mentorship has significantly influenced the next generation of psychiatric professionals in Greece. By addressing critical aspects of psychiatric education and psychopathology, her work continues to resonate within the medical community.

Legacy and Future Contributions 🔮

Dr. Margariti’s pioneering research on ‘Psychotic Arousal’ is poised to leave a lasting legacy in psychiatric literature. As she continues to explore the complexities of acute psychosis, her findings may lead to enhanced diagnostic and therapeutic approaches in psychiatry. With her ongoing commitment to research and education, she is well-positioned to make further significant contributions to the field.

 

Publications


📝 Psychotic Arousal and the Psychopathology of Acute Schizophrenia: An Exploratory Study of the Experiential Emotional State in Acute Psychosis
Authors: MM Margariti, II Vlachos, D Mpourazana, P Aristotelidis, M Selakovic, ...
Journal: Journal of Clinical Medicine
Year: 2024


📝 Frequent visitors in a university psychiatric emergency department in Greece
Authors: I Vlachos, P Chondraki, P Magioglou, E Lempesi, D Bourazana, ...
Journal: European Psychiatry
Year: 2022


📝 The concept of psychotic arousal and its relevance to abnormal subjective experiences in schizophrenia. A hypothesis for the formation of primary delusions
Authors: MM Margariti, II Vlachos
Journal: Medical Hypotheses
Year: 2022


📝Psychiatric specialty training in Greece: Comparative analysis of educational programs (2000 vs 2014)
Authors: M Margariti, C Papageorgiou
Journal: Psychiatrike= Psychiatriki
Year: 2017


 

Feifei Feng | Health Professions | Best Researcher Award

Dr. Feifei Feng | Health Professions | Best Researcher Award 

The Second Hospital of Shandong University | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Feifei Feng embarked on her academic journey in clinical medicine, obtaining a Master's degree through a seven-year program at Zhejiang University (2005-2012). She continued her education with a Doctor of Medicine (MD) degree in Internal Medicine from Qilu Medical College, Shandong University (2017-2020). Her academic training laid a robust foundation in both clinical and research aspects of internal medicine, particularly focusing on respiratory and critical care.

Professional Endeavors

Dr. Feng's professional career has been marked by her role as an Associate Chief Physician in the Department of Respiratory and Critical Care Medicine at the Second Hospital of Shandong University (09/2022 - Present). In this capacity, she is responsible for the daily consultation and treatment of patients with respiratory and critical care needs. Her work emphasizes the diagnosis and management of respiratory diseases, with a particular focus on lung cancer and pulmonary fibrosis.

Contributions and Research Focus

Dr. Feng's research has significantly contributed to understanding and treating respiratory diseases. Her research focus includes:

*Silicosis and Pulmonary Fibrosis: Dr. Feng has extensively studied the pathogenesis of silicosis and the therapeutic effects of compounds like Tanshinone IIA in attenuating silica-induced pulmonary fibrosis.

*Cancer Therapy: Her work on the inhibitory effects of polyphyllins and their role in enhancing chemosensitivity of cancer cells to treatments like cisplatin has been groundbreaking.

*Signaling Pathways: She has delved into the molecular mechanisms underlying disease processes, such as the TGF-β1/Smad signaling pathway, EMT, NOX4 inhibition, and Nrf2/ARE signaling activation.

Accolades and Recognition

Dr. Feng's contributions to the field have been widely recognized through numerous publications in high-impact journals. Some of her notable works include:

"Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA" (Biomed Pharmacother, 2024).

"Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling" (Chem Biol Interact, 2020).

Impact and Influence

Dr. Feng's research has had a profound impact on the medical community's understanding of respiratory diseases and their treatment. Her studies on the molecular pathways involved in pulmonary fibrosis and cancer therapy have opened new avenues for developing targeted treatments. By elucidating the mechanisms of disease and identifying potential therapeutic agents, her work has contributed to improved patient outcomes and advanced the field of respiratory medicine.

Legacy and Future Contributions

Dr. Feng continues to make strides in her field through her ongoing clinical practice and research. Her dedication to understanding complex respiratory diseases and finding innovative treatments ensures that her contributions will have a lasting impact. Future research endeavors are likely to build on her current work, exploring new therapeutic targets and improving the quality of care for patients with respiratory diseases. Her legacy will be marked by her commitment to advancing medical science and improving patient health outcomes.

 

Notable Publications

Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA 2024

Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition 2019 (26)

Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling 2020 (52)

Polyphyllin I induces apoptosis and autophagy in temozolomide-resistant glioma via modulation of NRF2 and MAPK-signaling activation 2023 (2)

Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway 2022 (8)

Detection and significance of exosomal mRNA expression profiles in the cerebrospinal fluid of patients with meningeal carcinomatosis 2021 (6)

Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway 2021 (23)

 

 

 

 

Ao Gu | Medicine and Dentistry | Best Researcher Award

Dr. Ao Gu | Medicine and Dentistry | Best Researcher Award

Shanghai Jiao Tong University School of Medicine | China

Author profile

Scopus

Early Academic Pursuits

Dr. Ao Gu completed his M.B in Clinical Medicine at Hebei University Health Science Center and is pursuing a master's degree at Shanghai Jiao Tong University School of Medicine, focusing on antitumor-active molecules under Prof. Yingbin Liu's mentorship.

Professional Endeavors

With a background in Clinical Medicine, Dr. Gu's professional journey includes extensive research in therapeutic molecules. He actively contributes to the scientific community through his publications and ongoing academic pursuits.

Contributions and Research Focus

Dr. Gu's research primarily centers on exploring the therapeutic capabilities of antitumor-active molecules. His work spans various aspects of medicine and chemistry, ranging from patient-derived models to single-cell omics analysis.

Accolades and Recognition

Dr. Ao Gu has gained recognition for his significant contributions to the field, as evidenced by his publications in reputable scientific journals. His work has been acknowledged for its innovation and potential impact on cancer research.

Impact and Influence

Through his research, Dr. Gu has the potential to influence advancements in cancer treatment and therapeutic molecule development. His contributions add valuable insights to the scientific community's understanding of antitumor agents.

Legacy and Future Contributions

Dr. Ao Gu's legacy lies in his dedication to advancing medical knowledge and developing novel therapeutic approaches. His future contributions are anticipated to further enrich the field of oncology and inspire aspiring researchers in the pursuit of medical excellence.

Notable Publications

Six-Membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications 2023

Aggregation-enabled alkene insertion into carbon–halogen bonds 2023 (1)

Solvent-free and Catalyst-free Direct Alkylation of Alkenes 2023 (1)

Trisubstituted alkenes featuring aryl groups: stereoselective synthetic strategies and applications 2023 (3)

 

 

Yannick Allanore | Medicine and Dentistry | Best Research Article Award

Prof. Yannick Allanore | Medicine and Dentistry | Best Research Article Award

Université Paris Cité | France

Author Profile

Scopus

Early Academic Pursuits

Yannick Allanore commenced his academic journey at Paris Descartes University, obtaining a Master's degree in 1999, followed swiftly by a Medical Doctor certification in 2000. His commitment to specialization in Rheumatology led to a Certification in Rheumatology in 2001. His profound interest in the field culminated in a thesis on "Oxidative stress and systemic sclerosis," earning him a Physician Doctor title in 2004.

Professional Endeavors

His academic tenure unfolded as an Assistant Professor at Paris Descartes University's Rheumatology department at Cochin Hospital from 2005 to 2008. Allanore's research prowess was acknowledged with a Research Habilitation in 2005, focusing on the pathogenesis of systemic sclerosis. Subsequently, he served as a Post-doctoral researcher at INSERM U781 and U1016, delving into the genetic bases and chronic inflammation of systemic sclerosis.

Contributions and Research Focus

Allanore leads a groundbreaking research team at Institut Cochin, delving into pathogenesis and innovative therapies for fibro-inflammatory rheumatic diseases since 2018. His research delves into genetic and pathophysiological aspects of systemic sclerosis, cardio-pulmonary involvement, clinical trials, and endothelial progenitor cells in rheumatic diseases.

Accolades and Recognition

Professor Allanore boasts a substantial publication record, exceeding 480 papers in peer-reviewed journals, showcasing an impressive H-Index of 71. His contributions have earned him memberships in esteemed societies such as the French Rheumatology Society, American College of Rheumatology, and significant roles within EUSTAR and the World Scleroderma Foundation.

Impact and Influence

His leadership roles, including former chairman of EUSTAR and current vice-director of Institut Cochin, testify to his impact on the global rheumatology community. Allanore's multifaceted approach—integrating clinical research, genetic studies, cellular biology, and animal model platforms—underlines his comprehensive influence on understanding and treating chronic inflammatory rheumatic diseases.

Legacy and Future Contributions

Yannick Allanore's legacy lies in his pivotal contributions to unraveling the complexities of systemic sclerosis and related conditions. His leadership in research and academia continues to pave the way for innovative therapies and a deeper comprehension of these debilitating diseases. As vice-director of Institut Cochin, his ongoing dedication promises further advancements in the field of rheumatology.

Notable Publications

Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis 2023 (1)

Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital 2023 (2)

Comparison of subcutaneous and oral methotrexate initiation in rheumatoid arthritis in current practice 2023 (1)

 

 

Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

Dr. Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits

Sanita Maleskic Kapo began her academic journey at the University of Sarajevo, delving into Pharmacology, Clinical Pharmacology, and Toxicology, culminating in her medical doctorate. Her formative years as a general practitioner at the Primary Health Care Center in Bihać enriched her understanding of patient care and community health.

Professional Endeavors

Transitioning into academia, she embraced teaching roles at the Faculty of Medicine, Sarajevo. Starting as a teaching assistant, her dedication and expertise elevated her to the position of Senior Teaching Assistant. Simultaneously, she embarked on a journey towards a Ph.D. in Pharmacology, further deepening her scholarly pursuits. Additionally, her ongoing residency in Clinical Pharmacology amplifies her practical acumen in the field.

Contributions and Research Focus

Sanita's contributions extend across academia and clinical practice. Her research focus in Pharmacology and Clinical Toxicology underscores her commitment to advancing medical knowledge. This commitment is reflected in her concurrent pursuit of a Ph.D. and residency, showcasing a dedication to scholarly and practical excellence.

Accolades and Recognition

Sanita Maleskic Kapo's journey is enriched by her notable accomplishments and dedication, marking her as a standout professional. While specific accolades may not be explicitly outlined, her multifaceted roles and continued academic progression underscore her recognition within the academic and medical spheres.

Impact and Influence

Her impact resonates through her teaching engagements, shaping future medical professionals. Simultaneously, her research endeavors lay the groundwork for advancements in Pharmacology and Clinical Toxicology, potentially influencing medical practices and patient care.

Legacy and Future Contributions

Sanita's legacy lies in her multifaceted contributions to academia, clinical research, and patient care. Her continued pursuit of a Ph.D. and residency promises a future where her expertise will further illuminate the realms of Pharmacology and Clinical Toxicology, potentially leaving an indelible mark in the field.

Notable Publications

Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study 2017 (27)

Bioanthropological analysis of human occipital condyles using geometric morphometric method 2020 (5)

Analysis of gender differences on pyriform aperture of human skulls using geometric morphometric method 2021 (5)

Effects of topically applied diclofenac and ketoprofen on prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats 2021 (2)

Evaluation of long-term efficacy of disease-modifying agents in patients with relapsing-remitting multiple sclerosis 2019 (1)